This online education program features a dynamic exchange between 2 experts who provide practical guidance for navigating key challenges across the warm autoimmune hemolytic anemia (wAIHA) care continuum, from standardized diagnostic workup and risk stratification to management of relapsed, refractory, or high-risk disease. Expert faculty discuss evidence-informed treatment sequencing and relapse-ready care plans tailored to disease severity, transfusion needs, comorbidities, and safety considerations. The program also examines emerging therapeutic mechanisms and clinical evidence, including how efficacy, safety, patient priorities, and monitoring requirements may inform their integration into treatment pathways.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
No specific specialties targeted.
Address:
- 1301 Virginia Drive
Pricing
CME included with membership
| Free Registration | Free |
| Tufts-Affiliated HCP - Early Bird (by 10/5/26) | $75 |
| Tufts-Affiliated HCP - Standard | $175 |
| Trainees & Allied Health - Early Bird (by 10/5/26) | $75 |
| Trainees & Allied Health - Standard | $175 |
| Physicians - Early Bird (by 10/5/26) | $150 |
+3 more tiers
Collected from the provider’s public pages · source
Specialties served/covered
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General & Adult Psychiatry
- General Pediatrics
- Gynecologic Oncology
- Head & Neck Surgery
- Hematology
- Maternal-Fetal Medicine
- Medical Genetics & Genomics
- Medical Oncology
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Ophthalmology
- Pediatric Neurology
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Radiation Oncology
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Transplant Hepatology
- Urological Oncology
- Vascular Neurology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 0.5 credits
- Commercial Support
-
Available fromOct 30, 2026
-
Last day to claim creditOct 31, 2027 1 year left
-
Talem Health, LLC Navigating Resistance, Relapse, and Treatment Sequencing in Relapsed/Refractory CLL
-
PRIME Education, Inc. (PRIME®) Selection of Bispecific Antibodies in Late MM Relapse: Key Factors and Considerations
-
RedMedEd +1 Exploring Recent Advances in Therapy for Patients With a First or Later Relapse of Multiple Myeloma – Activity 1
-
Global Learning Collaborative What the Evidence Demands: A Clinician s Decision Framework for LR-MDS Anemia Management
-
Global Learning Collaborative Data Meets Decision: Expert Approaches to Perioperative Immunotherapy in LA HNSCC
-
Global Learning Collaborative The Frontline Imperative: Integrating Anti-CD38 Based Regimens Into Multiple Myeloma Care in Community Practice
